(Press-News.org) The lipidation states (or modifications) in certain proteins in the brain that are related to the development of Alzheimer disease appear to differ depending on genotype and cognitive diseases, and levels of these protein and peptides appear to be influenced by diet, according to a report published Online First by JAMA Neurology, a JAMA Network publication.
Sporadic Alzheimer disease (AD) is caused in part by the accumulation of β-amyloid (Αβ) peptides in the brain. These peptides can be bound to lipids or lipid carrier proteins, such as apolipoprotein E (ApoE), or be free in solution (lipid-depleted [LD] Αβ). Levels of LD Αβ are higher in the plasma of adults with AD, but less is known about these peptides in the cerebrospinal fluid (CSF), the authors write in the study background.
Angela J. Hanson, M.D., Veterans Affairs Puget Sound Health Care System and the University of Washington, Seattle, and colleagues studied 20 older adults with normal cognition (average age 69 years) and 27 older adults with amnestic mild cognitive impairment (average age 67 years).
The patients were randomized to a diet high in saturated fat content (45 percent energy from fat, greater than 25 percent saturated fat) with a high glycemic index or a diet low in saturated fat content (25 percent of energy from fat, less than 7 percent saturated fat) with a low glycemic index. The main outcomes the researchers measured were lipid depleted (LD) Αβ42 and Αβ40 and ApoE in cerebrospinal fluid.
Study results indicate that baseline levels of LD Αβ were greater for adults with mild cognitive impairment compared with adults with normal cognition. The authors also note that these findings were more apparent in adults with mild cognitive impairment and the Ɛ4 allele (a risk factor for AD), who had higher LD apolipoprotein E levels irrespective of cognitive diagnosis. Study results indicate that the diet low in saturated fat tended to decrease LD Αβ levels, whereas the diet high in saturated fat increased these fractions.
The authors note the data from their small pilot study need to be replicated in a larger sample before any firm conclusions can be drawn.
"Overall, these results suggest that the lipidation states of apolipoproteins and amyloid peptides might play a role in AD pathological processes and are influenced by APOE genotype and diet," the study concludes.
(JAMA Neurol. Published online June 17, 2013. doi:10.1001/jamaneurol.2013.396. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: This study was supported by grants from the Hartford Center of Excellence and the National Institute on Aging, by the Nancy and Buster Alvord Endowment and by the Department of Veterans Affairs. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Food for Thought
In an editorial, Deborah Blacker, M.D., Sc.D., of the Massachusetts General Hospital/Harvard Medical School, Boston, writes: "The article by Hanson and colleagues makes a serious effort to understand whether dietary factors can affect the biology of Alzheimer disease (AD)."
"Hanson et al argue that the changes observed after their two dietary interventions may underlie some of the epidemiologic findings regarding diabetes and other cardiovascular risk factors and risk for AD. The specifics of their model may not capture the real underlying biological effect of these diets, and it is unclear whether the observed changes in the intermediate outcomes would lead to beneficial changes in oligomers or plaque burden, much less to decreased brain atrophy or improved cognition," she continues.
"At some level, however, the details of the biological model are not critical; the important lesson from the study is that dietary intervention can change brain amyloid chemistry in largely consistent and apparently meaningful ways – in a short period of time. Does this change clinical practice for those advising patients who want to avoid dementia? Probably not, but it adds another small piece to the growing evidence that taking good care of your heart is probably good for your brain too," Blacker concludes.
(JAMA Neurol. Published online June 17, 2013. doi:10.1001/jamaneurol.2013.3288. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: This work was made possible by grants from the National Institutes of Health/National Institute on Aging. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
### END
Study of dietary intervention examines proteins in brain
2013-06-18
ELSE PRESS RELEASES FROM THIS DATE:
Study finds the sweet spot -- and the screw-ups -- that make or break environmental collective actions
2013-06-18
Sustainability programs are a Goldilocks proposition – some groups are too big, some are too small, and the environment benefits when the size of a group of people working to save it is just right.
It has long been debated how many people working together can change the world. Whether it's joining forces to conserve gas, save a forest or stave off climate change, arguments have been made for the power of a dedicated few or the strength of numbers. It also has been a mystery what tips a group dynamic from powerful to unproductive.
Scientists at Michigan State University ...
1 step closer to a vaccine for a common respiratory disease
2013-06-18
RSV is a common cause of respiratory infection, but there is no vaccine available. It causes flu-like symptoms in healthy adults, but becomes life-threatening in young children and the elderly. It is estimated to cause over 100 000 deaths yearly worldwide.
The teams of Research Director Sarah Butcher (Institute of Biotechnology, University of Helsinki) and Professor Ari Helenius (ETH Zurich) have now solved the three-dimensional structure of RSV.
"The structural model helps us to understand how infectious viruses are formed. This information can be useful in the intelligent ...
Treating infection may have sting in the tail, parasite study shows
2013-06-18
Using drugs to treat an infection could allow other co-existing conditions to flourish, a study in wild animals has shown.
Researchers studying wild mice – which typically carry multiple parasitic infections at once – found that when these animals were treated for one type of bug, other infections they had tended to worsen.
The findings suggest that infections that co-exist in our bodies can compete with each other to alter disease. Treating one infection may have unintended consequences by enabling others to gain a stronger foothold – perhaps to the overall detriment ...
Testosterone therapy may help improve pain in men with low testosterone
2013-06-18
SAN FRANCISCO—- Testosterone therapy is associated with decreased pain perception in men with low testosterone levels related to
opioid (narcotic) pain relievers (analgesics), a new study finds. The results were presented Monday at The Endocrine Society's 95th
Annual Meeting in San Francisco.
"In this study, we attempted to determine whether testosterone replacement improves pain perception and tolerance, and quality of
life in men with low testosterone levels due to narcotic analgesics," said the study's lead author Shehzad Basaria, MD, Medical Director,
Section ...
Investigational drug improves sleep disorder among the blind
2013-06-18
SAN FRANCISCO—- An investigational new drug significantly improved a common and debilitating circadian rhythm sleep disorder that frequently affects people who are completely blind, a multicenter study finds. The results were presented Monday at The Endocrine Society's Annual Meeting in San Francisco.
The new drug, called tasimelteon, selectively targets the master body clock in the brain, which controls the timing of the sleep-wake cycle, alertness patterns and the timing of some hormones, as well as many other aspects of physiology and metabolism. This study found that ...
Testosterone improves verbal learning and memory in postmenopausal women
2013-06-18
SAN FRANCISCO—- Postmenopausal women had better improvement in verbal learning and memory after receiving treatment with testosterone gel, compared with women who received sham treatment with a placebo, a new study found. Results were presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.
"This is the first large, placebo-controlled study of the effects of testosterone on mental skills in postmenopausal women who are not on estrogen therapy," said principal investigator Susan Davis, MBBS (MD), PhD, of Monash University, Melbourne, Australia. ...
High-fat diet during pregnancy contributes to offspring's increased weight
2013-06-18
SAN FRANCISCO-- Exposure to a high-fat diet in the womb and after birth can permanently change the cells in the brain that control food intake, predisposing monkeys to overeating and an increased preference for fatty and sugary foods, a new study finds. The results were presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.
The study, funded by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases, also found that male offspring of maternal monkeys that ate a high-fat diet had increased body weight, ...
Naturally occurring hormone induces egg maturation
2013-06-18
SAN FRANCISCO-- The naturally occurring hormone kisspeptin effectively induces egg maturation during infertility treatment, according to a clinical in vitro fertilization (IVF) study. The results were presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.
Aptly named after the popular chocolate Hershey's kiss candy, kisspeptin was discovered in Hershey, PA, in 1996. Released by the brain in both males and females, the hormone triggers the development of secondary sexual characteristics and other changes of puberty.
Each year, thousands of ...
New way to improve antibiotic production
2013-06-18
An antibiotic has been found to stimulate its own production. The findings, to be published in PNAS, could make it easier to scale up antibiotic production for commercialisation.
Scientists Dr Emma Sherwood and Professor Mervyn Bibb from the John Innes Centre were able to use their discovery of how the antibiotic is naturally produced to markedly increase the level of production.
"We have shown for the first time that an antibiotic with clinical potential can act as signalling molecule to trigger its own synthesis," said Professor Bibb.
The antibiotic called planosporicin ...
Pesticides significantly reduce biodiversity in aquatic environments
2013-06-18
This news release is available in German. Washington/Leipzig/Sydney. The pesticides, many of which are currently used in Europe and Australia, are responsible for reducing the regional diversity of invertebrates in streams and rivers by up to 42 percent, researchers report in the Proceedings of the US Academy of Sciences (PNAS). Mikhail A. Beketov and Matthias Liess from the Helmholtz Centre for Environmental Research (UFZ) in Leipzig, together with Ben Kefford from the University of Technology, Sydney and Ralf B. Schäfer from the Institute for Environmental Sciences ...